Convatec Group PLC

Board/Management Information • Dec 21, 2020

National Storage Mechanism | Additional information

RNS Number : 3665J

ConvaTec Group PLC

21 December 2020

ConvaTec Director Declaration

Reading, United Kingdom (21 December 2020)

ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Brian May, Non-Executive Director of the Company, has been appointed as Non-Executive Director of Ferguson plc (LSE:FERG), effective 1 January 2021. Upon Mr May's appointment, he will also join the Nominations and Audit Committees.

This announcement is made in accordance with Listing Rule 9.6.14R.

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations &

Corporate Communications, ConvaTec                                    +44 (0)7826 447807

ir@convatec.com

Media

Buchanan: Charles Ryland / Chris Lane                                    +44 (0)207 466 5000                                                                                                 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNPPGCCPUPUGUG